Immuron CEO Steven Lydeamore presented at AusBioInvest

Rhea-AI Summary

Immuron Limited presented at AusBioInvest 2023, an Australian biopharmaceutical company. The CEO presented on October 30th, and the presentation is available on the company's website. Contact information: Steven Lydeamore, CEO, +61 (0)3 9824 5254, info@immuron.com.

MELBOURNE, Australia, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company, is pleased to advise our Chief Executive Officer, Steven Lydeamore, presented at AusBioInvest 2023 on Monday, October 30th in the 9.40am – 10.35am session (AEST) at the Park Hyatt, Melbourne, Australia.

A copy of the presentation being made at AusBioInvest 2023 is available on the Company’s website.

https://www.immuron.com.au/corporate-presentations/

This release has been authorised by the directors of Immuron Limited.

COMPANY CONTACT:

Steven Lydeamore
Chief Executive Officer
Ph: +61 (0)3 9824 5254
info@immuron.com

About Immuron
Immuron Limited (ASX: IMC, NASDAQ: IMRN), is an Australian biopharmaceutical company focused on developing and commercialising orally delivered targeted polyclonal antibodies for the treatment of infectious diseases.

For more information visit: http://www.immuron.com

FAQ

Who presented at AusBioInvest 2023?

Steven Lydeamore, CEO of Immuron Limited, presented at AusBioInvest 2023.

When did the presentation take place?

The presentation took place on October 30th.

Where was the presentation held?

The presentation was held at the Park Hyatt in Melbourne, Australia.

Where can I find the presentation?

The presentation is available on Immuron Limited's website at https://www.immuron.com.au/corporate-presentations/.

How can I contact Immuron Limited?

You can contact Steven Lydeamore, the CEO of Immuron Limited, at +61 (0)3 9824 5254 or info@immuron.com.